Forefront
Forefront Podcast: Who Owns the Verdict?
55:59
OpenAI announced on October 20, 2026 that it had acquired Orchestra Bio and folded it into Rosalind, its life sciences tools. This flagship episode argues that owning the process only matters if it moves the verdict: better kill, continue, or submit decisions backed by evidence that survives regulatory scrutiny. OpenAI does not own the verdict today, and this episode lays out the checklist that…